Literature DB >> 25123261

The application of micro-vacuo-certo-contacting ophthalmophanto in X-ray radiosurgery for tumors in an eyeball.

Shuying Li1, Yunyan Wang, Likuan Hu, Yingchun Liang, Jing Cai.   

Abstract

The large errors of routine localization for eyeball tumors restricted X-ray radiosurgery application, just for the eyeball to turn around. To localize the accuracy site, the micro-vacuo-certo-contacting ophthalmophanto (MVCCOP) method was used. Also, the outcome of patients with tumors in the eyeball was evaluated. In this study, computed tomography (CT) localization accuracy was measured by repeating CT scan using MVCCOP to fix the eyeball in radiosurgery. This study evaluated the outcome of the tumors and the survival of the patients by follow-up. The results indicated that the accuracy of CT localization of Brown-Roberts-Wells (BRW) head ring was 0.65 mm and maximum error was 1.09 mm. The accuracy of target localization of tumors in the eyeball using MVCCOP was 0.87 mm averagely, and the maximum error was 1.19 mm. The errors of fixation of the eyeball were 0.84 mm averagely and 1.17 mm maximally. The total accuracy was 1.34 mm, and 95% confidence accuracy was 2.09 mm. The clinical application of this method in 14 tumor patients showed satisfactory results, and all of the tumors showed the clear rims. The site of ten retinoblastomas was decreased significantly. The local control interval of tumors were 6 ∼ 24 months, median of 10.5 months. The survival of ten patients was 7 ∼ 30 months, median of 16.5 months. Also, the tumors were kept stable or shrank in the other four patients with angioma and melanoma. In conclusion, the MVCCOP is suitable and dependable for X-ray radiosurgery for eyeball tumors. The tumor control and survival of patients are satisfactory, and this method can effectively postpone or avoid extirpation of eyeball.

Entities:  

Mesh:

Year:  2014        PMID: 25123261     DOI: 10.1007/s13277-014-2415-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  The University of Florida radiosurgery system.

Authors:  W A Friedman; F J Bova
Journal:  Surg Neurol       Date:  1989-11

2.  A system for stereotactic radiosurgery with a linear accelerator.

Authors:  W Lutz; K R Winston; N Maleki
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-02       Impact factor: 7.038

3.  Linear accelerator as a neurosurgical tool for stereotactic radiosurgery.

Authors:  K R Winston; W Lutz
Journal:  Neurosurgery       Date:  1988-03       Impact factor: 4.654

4.  Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.

Authors:  Xiao-Bing Jiang; Qun-Ying Yang; Ke Sai; Xiang-Heng Zhang; Zhong-Ping Chen; Yong-Gao Mou
Journal:  Tumour Biol       Date:  2011-09-13

5.  Localized whole eye radiotherapy for retinoblastoma using a (125)I applicator, "claws".

Authors:  C Stannard; R Sealy; E Hering; J Korrubel; J Hill; A Barron; R Knowles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

6.  External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines.

Authors:  J C Hernandez; L W Brady; J A Shields; C L Shields; P DePotter; U L Karlsson; A M Markoe; B E Amendola; A Singh
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-04-01       Impact factor: 7.038

7.  Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.

Authors:  Zhe Wang; Xu Chen; Bo Liu; Shide Li; Mingjun Liu; Hong Xue
Journal:  Tumour Biol       Date:  2013-10-03

8.  Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma.

Authors:  S M Imhof; M P Mourits; P Hofman; F W Zonneveld; J Schipper; A C Moll; K E Tan
Journal:  Ophthalmology       Date:  1996-02       Impact factor: 12.079

9.  Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells.

Authors:  Cheng-Jeng Tai; Jin-Wun Wang; Hou-Yu Su; Chen-Jei Tai; Chien-Kai Wang; Chun-Te Wu; Yung-Chang Lien; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-08-09

10.  Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma.

Authors:  Jianxin Shi; Ji Zhu; Heng Zhao; Chenxi Zhong; Zhiyun Xu; Feng Yao
Journal:  Tumour Biol       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.